Altamira Therapeutics Ltd. Cash Flows From Used In Financing Activities
Altamira Therapeutics Ltd. (CYTOF) reported Cash Flows From Used In Financing Activities of $367.94 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:CashFlowsFromUsedInFinancingActivities · last filed 2025-08-29
CHF
| Period end | Cash Flows From Used In Financing Activities 6 month | Cash Flows From Used In Financing Activities 12 month |
|---|---|---|
| 2023-12-31 | 10.62M CHF 20-F/A · filed 2024-04-22 | |
| 2023-06-30 | 7.70M CHF 6-K · filed 2023-09-12 | |
| 2022-12-31 | 9.83M CHF 20-F/A · filed 2024-04-22 | |
| 2022-06-30 | 6.54M CHF 6-K · filed 2023-09-12 | |
| 2021-12-31 | 6.61M CHF 20-F/A · filed 2024-04-22 | |
| 2021-06-30 | 3.84M CHF 6-K/A · filed 2023-08-21 | |
| 2020-12-31 | 16.96M CHF 20-F · filed 2023-05-16 | |
| 2020-06-30 | 1.04M CHF 6-K · filed 2021-09-08 | |
| 2019-12-31 | 7.38M CHF 20-F · filed 2022-04-12 | |
| 2019-06-30 | 7.24M CHF 6-K/A · filed 2020-09-17 | |
| 2018-12-31 | 5.73M CHF 20-F · filed 2021-03-31 | |
| 2018-06-30 | -3.10M CHF 6-K · filed 2019-08-15 | |
| 2017-12-31 | 8.22M CHF 20-F · filed 2020-04-16 | |
| 2016-12-31 | 11.44M CHF 20-F · filed 2019-03-14 | |
| 2015-12-31 | 20.92M CHF 20-F · filed 2018-03-22 |
USD
| Period end | Cash Flows From Used In Financing Activities 6 month | Cash Flows From Used In Financing Activities 12 month |
|---|---|---|
| 2025-06-30 | $367.94K 6-K · filed 2025-08-29 | |
| 2024-12-31 | $6.51M 20-F · filed 2025-04-30 | |
| 2024-06-30 | $2.51M 6-K · filed 2025-08-29 | |
| 2023-12-31 | $11.82M 20-F · filed 2025-04-30 | |
| 2023-06-30 | $8.41M 6-K · filed 2024-09-24 | |
| 2022-12-31 | $10.30M 20-F · filed 2025-04-30 |